Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial

Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial

Objective: to determine whether the immunogenicity of a single dose infant priming schedule of serogroup C meningococcal (MenC) conjugate vaccine is non-inferior to a two dose priming schedule when followed by a booster dose at age 12 months. Design: phase IV open label randomised controlled trial...

Full description

Bibliographic Details
Main Authors: Pace, D. (Author), Khatami, A. (Author), McKenna, J. (Author), Campbell, D. (Author), Attard-Montalto, S. (Author), Birks, J. (Author), Voysey, M. (Author), White, C. (Author), Finn, A. (Author), Macloed, E. (Author), Faust, S.N (Author), Kent, A.L (Author), Heath, P.T (Author), Borrow, R. (Author), Snape, M.D (Author), Pollard, A.J (Author)
Format: Article
Language:English
Published: 2015-04-01.
Subjects:
Article
Online Access:Get fulltext

Similar Items

Similar Items